Read Time:6 Second
Merck shares gained 3.8% in after-hours trading Tuesday following approval of its new drug for a potentially fatal lung disease.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
